Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5200225 | 6434118 | I | 5200225-1 | 20061021 | 20061226 | 20070105 | EXP | FR-PFIZER INC-2006155609 | PFIZER INC | 34 | YR | F | Y | 52 | KG | 20070105 | OT | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5200225 | 1008015913 | PS | CLINDAMYCIN HCL | 1 | ORAL | 50162 | |||||
| 5200225 | 1008015914 | SS | KALETRA | 1 | ORAL | ||||||
| 5200225 | 1008015915 | SS | ABACAVIR SULFATE LAMIVUDINE AND ZIDOVUDINE | 1 | ORAL | TEXT:1 DOSE FORM; 1 DOSE FORM-FREQ:FREQUENCY: DAILY | |||||
| 5200225 | 1008015916 | C | SULFADIAZINE | 1 | |||||||
| 5200225 | 1008015917 | C | PYRIMETHAMINE TAB | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5200225 | 1008015913 | TOXOPLASMOSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5200225 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 5200225 | GENERAL PHYSICAL HEALTH DETERIORATION |
| 5200225 | HYPERSENSITIVITY |
| 5200225 | INTERSTITIAL LUNG DISEASE |
| 5200225 | MULTI-ORGAN FAILURE |
| 5200225 | PYREXIA |
| 5200225 | RASH MACULO-PAPULAR |
| 5200225 | RESPIRATORY DISTRESS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5200225 | 1008015913 | 20061018 | 20061023 | ||
| 5200225 | 1008015915 | 20061016 | 20061023 |